The Framingham Offspring study found that 39% of the general population may be in the low normal + deficient B12 blood level range
CagriSema Combination Therapy: The Cagrilintide and Semaglutide Dosing Chart The CagriSema combination therapy represents an innovative approach that pairs cagrilintide with semaglutide, a GLP-1 receptor agonist
Daily administration of two or more synaptogenic compounds simultaneously might overwhelm cellular synthetic capacity or trigger compensatory downregulation faster than either compound would alone, potentially favoring alternating administration schedules where different compounds are used on different days
You'll often see it as an ingredient in face serums, creams, and even scalp care treatments because of the research behind its use for supporting collagen and elastin synthesis and skin tissue repair [1]
Last reviewed: May 29, 2026
The Mayo Clinic lists the following medications as reducing B12 absorption: Aminosalicylic acid (Paser), Colchicine (Colcrys, Mitigare, Gloperba), Metformin (Glumetza, Fortamet, others), and proton pump inhibitors